Page last updated: 2024-08-23

quinpirole and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

quinpirole has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19906 (25.00)18.7374
1990's13 (54.17)18.2507
2000's4 (16.67)29.6817
2010's1 (4.17)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bédard, PJ; Boucher, R; Gomez-Mancilla, B1
Bédard, PJ; Boucher, R; Gomez-Mancilla, B; Latulippe, JF1
Close, SP; Elliott, PJ; Walsh, DM1
Bruno, JP; Hadjiconstantinou, M; Weihmuller, FB1
Bédard, PJ; Boucher, R1
Schneider, JS1
Boyce, S; Clarke, CE; Crossman, AR; Robertson, RG; Sambrook, MA1
Jenner, P; Marsden, CD; Nomoto, M2
Jenner, P; Marsden, CD1
Johnson, BJ; Peacock, V; Schneider, JS1
Erol, DD; Gnanalingham, KK; Hunter, AJ; Jenner, P; Marsden, CD; Smith, LA1
Gnanalingham, KK; Hunter, AJ; Jenner, P; Marsden, CD1
Drukarch, B; Goosen, C; Sahadat, MC; Stoof, JC; Vermeulen, RJ; Wolters, EC1
Roeltgen, DP; Schneider, JS; Sun, ZQ1
Drukarch, B; Goosen, C; Sahadat, MC; Stoof, JC; van Royen, EA; Verhoeff, NP; Vermeulen, RJ; Wolters, EC1
Kuno, S; Mizuta, E; Sasa, M; Yoshida, O; Yoshimura, N1
Bédard, PJ; Britton, DR; Grondin, R; Shiosaki, K1
Andringa, G; Cools, AR; Drukarch, B; Stoof, JC; Vermeulen, RJ1
Jackson, MJ; Jenner, P; Kanda, T; Kase, H; Kuwana, Y; Nakamura, J; Pearce, RK; Smith, LA1
Jackson, M; Jenner, P; Treseder, SA1
Jenner, P; Smith, LA; Treseder, SA1
Bédard, PJ; Grégoire, L; Samadi, P1
Chen, T; Hu, G; Huang, YY; Li, SB; Liu, YJ; Shao, W; Tang, M; Wawrousek, E; Xu, M; Yin, YQ; Zhang, SZ; Zhang, XH; Zhou, JN; Zhou, JW; Zhou, QB; Zhou, Z1

Reviews

1 review(s) available for quinpirole and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Journal of neural transmission. Supplementum, 1986, Volume: 20

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Callithrix; Corpus Striatum; Disease Models, Animal; Dopamine; Ergolines; Humans; Levodopa; Macaca mulatta; Neural Pathways; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Quinpirole; Rats; Saimiri; Selegiline; Species Specificity; Substantia Nigra

1986

Other Studies

23 other study(ies) available for quinpirole and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Dopamine Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electromyography; Ergolines; Female; Indoles; Injections, Subcutaneous; Macaca fascicularis; Parkinson Disease, Secondary; Phenanthridines; Quinpirole; Tremor

1992
Effect of ethosuximide on rest tremor in the MPTP monkey model.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Diltiazem; Dopamine Agents; Dose-Response Relationship, Drug; Electromyography; Ergolines; Ethosuximide; Female; Macaca fascicularis; Neurologic Examination; Parkinson Disease, Secondary; Quinpirole; Tremor; Verapamil

1992
Dopamine D1 and D2 receptor interactions in the MPTP-treated marmoset.
    Neuroscience letters, 1992, Aug-03, Volume: 142, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Callithrix; Dopamine Agents; Ergolines; Female; Levodopa; Male; Movement; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2

1992
Dopamine receptors and sensorimotor behavior in MPTP-treated mice.
    Behavioural brain research, 1990, May-28, Volume: 38, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arousal; Benzazepines; Discrimination Learning; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Orientation; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride

1990
Effect of D1 receptor stimulation in normal and MPTP monkeys.
    Neuroscience letters, 1989, Sep-25, Volume: 104, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Ergolines; Female; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Sulpiride

1989
Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 34, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Ergolines; Levodopa; Macaca fascicularis; Parkinson Disease, Secondary; Quinpirole

1989
Drug-induced dyskinesia in primates rendered hemiparkinsonian by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Journal of the neurological sciences, 1989, Volume: 90, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Dose-Response Relationship, Drug; Ergolines; Injections, Intravenous; Levodopa; Macaca fascicularis; Movement Disorders; Parkinson Disease, Secondary; Pyridines; Quinpirole; Stereotyped Behavior

1989
The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset.
    Neuroscience letters, 1988, Nov-11, Volume: 93, Issue:2-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Callithrix; Dopamine Agents; Ergolines; Female; Male; Motor Activity; Pyridines; Quinpirole

1988
The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
    Neuroscience letters, 1985, Jun-04, Volume: 57, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Benzazepines; Callitrichinae; Ergolines; Female; Male; Parkinson Disease, Secondary; Pyridines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2

1985
Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys.
    Pharmacology, biochemistry, and behavior, 1995, Volume: 51, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Benzazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Ergolines; Functional Laterality; Macaca mulatta; Male; Parkinson Disease, Secondary; Phenanthridines; Quinpirole; Raclopride; Receptors, Dopamine D1; Rotation; Salicylamides

1995
Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset.
    Psychopharmacology, 1995, Volume: 117, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Benzazepines; Binding, Competitive; Callithrix; Dopamine Agonists; Ergolines; In Vitro Techniques; Male; Parkinson Disease, Secondary; Quinpirole; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone

1995
The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease.
    Psychopharmacology, 1995, Volume: 117, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenylyl Cyclases; Animals; Behavior, Animal; Callithrix; Dopamine Agonists; Ergolines; Female; In Vitro Techniques; Male; Parkinson Disease, Secondary; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Species Specificity

1995
The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Corpus Striatum; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Macaca mulatta; Male; Motor Activity; Motor Skills; Parkinson Disease, Secondary; Psychomotor Performance; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Substantia Nigra

1994
Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 48, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Conditioning, Operant; Dopamine Agents; Ergolines; Female; Macaca; Male; Methylphenidate; Psychomotor Performance; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2

1994
No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys.
    Synapse (New York, N.Y.), 1994, Volume: 17, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcholine; Animals; Behavior, Animal; Benzamides; Binding, Competitive; Dopamine Agents; Dopamine D2 Receptor Antagonists; Ergolines; Functional Laterality; Macaca mulatta; Male; Neostriatum; Pyrrolidines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Rotation; Stereotyped Behavior; Tomography, Emission-Computed, Single-Photon

1994
The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Neuropharmacology, 1993, Volume: 32, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Dopamine Agents; Ergolines; Macaca fascicularis; Male; Parkinson Disease, Secondary; Quinpirole; Reflex; Urinary Bladder; Urination

1993
Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys.
    Neurology, 1997, Volume: 49, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Quinolones; Quinpirole; Receptors, Dopamine D1; Thiophenes

1997
Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease.
    Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Benzazepines; Dopamine Agonists; Haplorhini; Levodopa; Motor Activity; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1

1998
Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys.
    Experimental neurology, 2000, Volume: 162, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Callithrix; Carbidopa; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Injections, Intraperitoneal; Levodopa; Male; Motor Activity; Parkinson Disease, Secondary; Purinergic P1 Receptor Antagonists; Purines; Quinpirole; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2

2000
The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primates.
    British journal of pharmacology, 2000, Volume: 129, Issue:7

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Callithrix; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hydrazines; Levodopa; Male; Motor Activity; Quinolones; Quinpirole; Thiophenes; Tyrosine

2000
Endogenous dopaminergic tone and dopamine agonist action.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Apomorphine; Benzopyrans; Callithrix; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Levodopa; Locomotion; Male; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase

2000
Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.
    Neuropharmacology, 2003, Volume: 45, Issue:7

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Dopamine; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Endorphins; Female; Levodopa; Macaca fascicularis; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission

2003
Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin.
    Nature, 2013, Feb-07, Volume: 494, Issue:7435

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Crystallin B Chain; Animals; Astrocytes; Dopaminergic Neurons; Immunity, Innate; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Quinpirole; Receptors, Dopamine D2; Substantia Nigra

2013